Al Altomari
Chief Executive Officer bij AGILE THERAPEUTICS, INC.
Vermogen: 789 331 $ op 31-03-2024
Profiel
Alfred F.
Altomari is currently the Chairman & Chief Executive Officer at Agile Therapeutics, Inc. since 2016.
He is also an Independent Director at Insmed, Inc. since 2012 and a Director at Trenton Area Soup Kitchen since 2015.
Additionally, he serves as a Trustee at Drexel University.
In his former positions, Mr. Altomari served as the Chief Executive Officer & Director at Barrier Therapeutics, Inc. from 2008 to 2011.
He was also the Chairman at NB Therapeutics from 2010 to 2013 and Baudax Bio, Inc. from 2019 to 2022.
Furthermore, he held director roles at DUSA Pharmaceuticals, Inc., Signum Biosciences, Inc., Auxilium Pharmaceuticals LLC, Societal CDMO, Inc., and Nitric Bio, Inc. He also served as a Trustee at BioNJ, Inc.Mr. Altomari obtained his undergraduate degree from Drexel University in 1982 and an MBA from Rider University in 1986.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INSMED INCORPORATED
0.02% | 11-05-2023 | 28 496 ( 0.02% ) | 773 096 $ | 31-03-2024 |
AGILE THERAPEUTICS, INC.
0.70% | 28-06-2023 | 47 749 ( 0.70% ) | 16 235 $ | 31-03-2024 |
Actieve functies van Al Altomari
| Bedrijven | Functie | Begin |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Chief Executive Officer | 01-10-2010 |
| INSMED INCORPORATED | Director/Board Member | 02-08-2012 |
| Trenton Area Soup Kitchen | Director/Board Member | 01-01-2015 |
| Drexel University | Director/Board Member | - |
Eerdere bekende functies van Al Altomari
| Bedrijven | Functie | Einde |
|---|---|---|
| BAUDAX BIO, INC. | Chairman | 04-05-2022 |
| SOCIETAL CDMO, INC. | Director/Board Member | 06-03-2021 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Chief Executive Officer | 18-04-2011 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Director/Board Member | - |
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Director/Board Member | - |
Opleiding van Al Altomari
| Drexel University | Undergraduate Degree |
| Rider University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| AGILE THERAPEUTICS, INC. | Health Technology |
| SOCIETAL CDMO, INC. | Health Technology |
| BAUDAX BIO, INC. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |
Signum Biosciences, Inc.
 Signum Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Signum Biosciences, Inc. develops therapeutic, dermatologic and dietary products. The company was founded by Jeffry B. Stock and Maxwell B. Stock in 2003 and is headquartered in Monmouth Junction, NJ | Commercial Services |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
NB Therapeutics
 NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Nitric Bio, Inc.
 Nitric Bio, Inc. Pharmaceuticals: MajorHealth Technology Nitric Bio, Inc. develops therapies for podiatry and dermatology. It addresses inherent challenges of drug delivery for diseases of the skin and nails through iontophoresis and nitric oxide gas technology platforms. The company was founded by Frank J. McCaney and is headquartered in Bristol, PA. | Health Technology |
| Trenton Area Soup Kitchen |
